| Teva Pharma AG - Bosutinib-Teva 500 mg, Filmtabletten | | 69223 | | 03 | | Bosutinib-Teva 500 mg | | Filmtabletten | | L01EA04 | | Bosutinib | | 28.05.2024 | | |
| | Composition | | bosutinibum 500 mg ut bosutinibum dihydricum, cellulosum microcristallinum, crospovidonum, poloxamerum 188, povidonum K 25, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, talcum, E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Bosutinibum | 500 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Rubrum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Poloxamer | 188 | | | Povidonum K | 25 | | | Pro Compresso Obducto | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 28 | PR | PR | A | | Yes |
|
|
